Aidi injection / hepatoP Cancer Research Results

Aidi, Aidi injection: Click to Expand ⟱

Features:

Aidi Injection - Chinese herbal anticancer injection

Type: Multi-component traditional Chinese medicine injectable formulation

Components: Mylabris phalerata / Cantharis (including cantharidin-related constituents), Astragalus membranaceus, Panax ginseng, and Acanthopanax senticosus (Eleutherococcus senticosus).

Function: Multi-component anticancer formulation used primarily as an adjunct to chemotherapy and radiotherapy. Reported actions include inhibition of tumor-cell proliferation, induction of apoptosis, modulation of immune responses, inhibition of invasion and metastasis, and reduction of chemotherapy-associated hematologic, gastrointestinal, hepatic, and renal toxicity.

Cancer: ↓ Tumor growth/progression. Clinical studies and meta-analyses, primarily from China, report improved objective response rate, disease control rate, and quality of life when Aidi injection is combined with conventional chemotherapy in several cancers. Evidence quality ranges from moderate to very low, and substantial geographic, publication, and methodological bias remain concerns.

hepatoP, L,hepatoprotective: Click to Expand ⟱

Source:

Type:

Hepatoprotective is the ability of a chemical substance to prevent damage to the liver.

Grapefruit:
-hepatoprotective potential has emerged from the study of naringenin and naringin.
Blueberries/cranberries:
-proanthocyanidins
Grape:
Nopal (Cactus pear) and tuna (Cactus pear fruit) “Opuntia ficus-indica”:
Chamomile (Matricaria chamomilla or Chamomilla recutita):
Silymarin (Silybum marianum):
Blue green algae spirulina :
Propolis (bee glue):

POLYSACCHARIDES
β-glucans

Scientific Papers found: Click to Expand⟱

7290-

PacT,

Aidi,

Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines

Dose↝, QoL↑, hepatoP↑, GastroP↑, chemoP↑, Dose↝,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Barriers & Transport(tgid=15) ⓘ

GastroP↑, 1,

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 2,

Functional Outcomes(tgid=23) ⓘ

chemoP↑, 1, hepatoP↑, 1, QoL↑, 1,
Total Targets: 5

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: hepatoP, L,hepatoprotective

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells